EHC
$119.80+0.62%
as of close, Oct 2, 2026
☾ AH $119.80 +0.62%
Encompass Health CorporationStock · Health CareRussell 1000 0.01%Russell 3000 0.01%US Stock Market 0.01%
EHC — Encompass Health Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDED
40.050.060.070.080.090.0100.0110.0120.0020.0M$119.80—20162019202120242026
2026-10-02
Price$119.80
MA20$111.49
MA50$112.00
Vol6.1M
Key stats
Price data
- Price
- $119.80
- Change YTD
- +12.87%
- Next earnings
- Nov 4, 2026
- Market cap
- 11.8B
- Enterprise value
- 15.7B
- Shares outstanding
- 98.7M
- 52W low
- $92.77
- 52W high
- $127.99
- From 52W high
- -6.40%
- From 52W low
- +29.14%
- 52W range
- 77%
- Beta
- 0.77
Volume
- Rel volume
- 1.25×
- 30D volume
- 874.3K
- 30D $ vol
- 106.4M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$26.4M
- Insider net 1Y
- −$47.8M
Form 4 transactions by trade date, as filed; latest on file 2026-08-31.
Fundamentals
- Sales (ttm)
- 6.2B
- Sales/share
- $62.91
- EPS (ttm)
- $6.14
- FCF (ttm)
- 413.4M
- FCF/share
- $4.19
- Book value/share
- $26.33
- Net margin
- 10.01%
- ROE
- 23.91%
- ROA
- 8.33%
- Debt / equity
- 1.00×
- Current ratio
- 1.19
Growth (CAGR, ttm) · 10Y
- Sales
- +9.48%+10.70%+7.37%+5.77%
- Net income
- +18.82%+25.53%+10.08%+11.02%
- FCF
- -5.88%+49.41%-0.72%-1.18%
- Shares
- -2.06%-0.53%-0.17%+0.95%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +19.97%+25.42%+9.83%+10.46%
- Sales/share
- +11.78%+11.29%+7.55%+4.64%
- FCF/share
- -3.90%+50.21%-0.55%-2.11%
- Book value/share
- +16.33%+21.39%+8.26%+13.39%
- Dividend/share
- +11.77%+8.20%-7.46%-1.89%
- Price
- -3.04%+21.58%+15.30%+14.01%
- Total return
- -2.32%+22.45%+16.42%+15.57%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 19.5×
- P/OI (ttm)
- 21.9×
- Fwd P/E
- 18.6×
- P/S (ttm)
- 1.9×
- P/B (mrq)
- 4.5×
- P/FCF (ttm)
- 28.6×
- EV/EBITDA (fy)
- 12.0×
- EV/Sales (ttm)
- 2.5×
- FCF yield (ttm)
- 3.50%
- Dividend yield (fwd)
- 0.63%
- Dividend yield (ttm)
- 0.63%
- Dividend/share (fwd)
- $0.76
- Buyback yield (realized, 1y)
- 2.06%
- Shareholder yield (realized, 1y)
- 2.67%
- Buyback yield (cash, ttm)
- 2.09%
- Shareholder yield (cash, ttm)
- 2.73%
Vs own 10Y history
- P/E
- 60th
- P/OI
- 94th
- P/S
- 90th
- P/B
- 72nd
- P/FCF
- 74th
Bar = where today’s multiple sits in EHC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-02
1D
+0.62%
5D
-2.97%
1M
-1.14%
3M
+12.53%
YTD
+12.87%
1Y
-3.04%
5Y
+103.83%
Recent filings
- Aug 31Insider sale · Price Andrew L (Chief Accounting Officer) sold 5,211 shares for $630K at $120.93
- Aug 31Insider sale · Darby John Patrick (EVP, Gen Counsel & Secretary) sold 4,858 shares for $588K at $121.09
- Aug 138-K · Other events
- Aug 10Insider sale · Tarr Mark J (President & CEO · Director) sold 173,148 shares for $21.7M at $125.46–$126.06
- Aug 10Insider sale · COLTHARP DOUGLAS E (EVP & Chief Financial Officer) sold 18,869 shares for $2.4M at $125.38
Financial statements
Open full EHC financials →Loading financial statements…
Related Health Care
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -13.21% | -0.04% |
| NVO | Novo Nordisk A/S | -20.21% | -0.21% |
| SNY | Sanofi ADS | -10.23% | -1.84% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -6.76% | -0.32% |
| NTRA | Natera Inc. | +26.20% | +0.46% |
| ARGX | argenx SE American Depositary Shares | -12.90% | -1.79% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | -3.09% | +0.00% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +5.44% | +0.56% |
